The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
Today, the
FDA announced that it is revising recommendations in several guidances regarding blood donor eligibility. These changes are based on recently completed studies and epidemiological data, leading the FDA to conclude that the polices could be modified without compromising the safety of the blood supply. The changes being announced to three guidances (HIV, malaria and CJD/vCJD) are for immediate implementation, and are expected to remain in place after the COVID-19 pandemic ends, with any appropriate changes based on...
.png)
No hay comentarios:
Publicar un comentario